Pathology News
Roche (RHHBY) said that it has received CE Mark approval for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx, enabling the identification of metastatic breast cancer patients with low HER2 expression who may benefit from ENHERTU...
CHICAGO--(BUSINESS WIRE)--Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration...
The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs,...
From the Lumea Podcast - Ask A Pathologist: Welcome to our seventh episode of the Ask a Pathologist Podcast, Innovators in Action. We had the privilege to interview Dr. Todd Randolph about artificial intelligence and its current and future...
Incyte: Pathology clinic installs ultra-fast slide scanners, prepares for AI future February 29, 2024 Karina Elias Diagnostic pathology clinic Incyte Diagnostics has installed two digital pathology slide scanners at its...
Nijmegen, The Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a partnership with Ziekenhuis aan de Stroom (ZAS) Netwerk, a...
